ArticleBMC pulmonary medicine2017

Case report: continued treatment with alectinib is possible for patients with lung adenocarcinoma with drug-induced interstitial lung disease.

Tatsuya Nitawaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.